The National Kidney Foundation (NKF) announced that nephrologist Paul M. Palevsky as the next president of its board of directors. Palevsky, a Pitt professor of medicine and chief of kidney medicine at the VA Pittsburgh Healthcare System, will serve a two-year term.
“I am honored and humbled by the opportunity to help lead the NKF and to advocate for the estimated 37 million adults in the U.S. with kidney disease and the millions more at risk,” Palevsky said. “The COVID-19 pandemic has made apparent the vulnerabilities of patients with kidney disease and has highlighted disparities in medical care, particularly among minority communities, that we must address."
Palevsky is internationally recognized as an expert in acute kidney injury and critical care nephrology and has helped lead multiple clinical trials focused on management of acute dialysis, prevention of acute kidney injury and slowing the progression of diabetic kidney disease.
The board meets three times per year and is charged with fiduciary, fundraising and governance responsibilities for NKF.